| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Jürg Utzinger | Q28324256 |
| Michael J. Doenhoff | Q41456714 | ||
| P2093 | author name string | Donato Cioli | |
| P2860 | cites work | Identification of an antimalarial synthetic trioxolane drug development candidate | Q22061876 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schistosomiasis | Q221159 |
| praziquantel | Q424145 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 659-667 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | |
| P478 | volume | 21 |
| Q99635896 | 30 years of parasitology research analysed by text mining |
| Q52677297 | A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing. |
| Q89823709 | A Review of Nanotechnology for Targeted Anti-schistosomal Therapy |
| Q39161231 | A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants. |
| Q39091997 | A conventional polymerase chain reaction-based method for the diagnosis of human schistosomiasis in stool samples from individuals in a low-endemicity area |
| Q37697955 | A multidisciplinary, integrated approach for the elimination of schistosomiasis: a longitudinal study in a historically hyper-endemic region in the lower reaches of the Yangtze River, China from 2005 to 2014 |
| Q28476171 | A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility |
| Q36247094 | A survey of schistosome protein domain types: insights into unique biological properties |
| Q33486179 | A wake up call for urinary schistosomiasis: reconciling research effort with public health importance |
| Q37053762 | ABC multidrug transporters in schistosomes and other parasitic flatworms |
| Q37941754 | ABC transporters involved in drug resistance in human parasites. |
| Q38123553 | Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis |
| Q39467299 | Algorithmic Mapping and Characterization of the Drug-Induced Phenotypic-Response Space of Parasites Causing Schistosomiasis |
| Q91771868 | An Efficient Schistosoma japonicum Bivalent Membrane Protein Antigen DNA Vaccine Against Schistosomiasis in Mice |
| Q28544852 | An artemisinin derivative of praziquantel as an orally active antischistosomal agent |
| Q28545088 | Anthelmintic activity in vivo of epiisopiloturine against juvenile and adult worms of Schistosoma mansoni |
| Q56909277 | Antibody Responses to Schistosoma mansoni Schistosomula Antigens |
| Q36018841 | Antischistosomal activities of mefloquine-related arylmethanols |
| Q37674908 | Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms |
| Q40601229 | Antischistosomal activity of hederacochiside C against Schistosoma japonicum harbored in experimentally infected animals. |
| Q28547348 | Application of RNAi to Genomic Drug Target Validation in Schistosomes |
| Q60949181 | Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis |
| Q42015454 | Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control |
| Q55228407 | Atypical pharmacology of schistosome TRPA1-like ion channels. |
| Q62486477 | Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity |
| Q83769924 | Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice |
| Q38004814 | Biogenic amines and the control of neuromuscular signaling in schistosomes |
| Q38035721 | Cerebral and spinal schistosomiasis |
| Q37651018 | Characterization of Schistosoma japonicum CP1412 protein as a novel member of the ribonuclease T2 molecule family with immune regulatory function |
| Q34052174 | Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni |
| Q43701919 | Characterization of the cGMP-dependent protein kinase SmcGK1 of Schistosoma mansoni |
| Q36802409 | Characterization of the methionine sulfoxide reductases of Schistosoma mansoni |
| Q55604560 | Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase. |
| Q38630566 | Clinical implications of recent findings in schistosome proteomics |
| Q36884691 | Cloning and functional characterization of two calmodulin genes during larval development in the parasitic flatworm Schistosoma mansoni |
| Q34675128 | Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine |
| Q37680707 | Community knowledge, attitudes and practices on schistosomiasis in western Kenya--the SCORE Project |
| Q41758770 | Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties |
| Q34705499 | Comparative pharmacology of flatworm and roundworm glutamate-gated chloride channels: Implications for potential anthelmintics |
| Q34629346 | Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes |
| Q34705415 | Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis. |
| Q55000698 | Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis. |
| Q37463234 | Conquering 'snail fever': schistosomiasis and its control in China. |
| Q40173400 | Conservation of protein kinase a catalytic subunit sequences in the schistosome pathogens of humans |
| Q46964347 | Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges. |
| Q37771992 | Controlling schistosomiasis in Southeast Asia: a tale of two countries |
| Q37726920 | Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? |
| Q37565174 | CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. |
| Q89920010 | Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs |
| Q38093067 | Current drug targets for helminthic diseases |
| Q37682900 | DNA vaccines: a rational design against parasitic diseases. |
| Q36679169 | De novo transcriptomic analysis of the female and male adults of the blood fluke Schistosoma turkestanicum |
| Q36346161 | Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets |
| Q57822205 | Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents |
| Q39004176 | Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents |
| Q46243865 | Detection of duo-schistosome infection from filtered urine samples from school children in Zambia after MDA. |
| Q28483732 | Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis |
| Q36219372 | Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula |
| Q35590947 | Diagnosis and management of schistosomiasis |
| Q38152776 | Diagnosis and treatment of schistosomiasis in children in the era of intensified control |
| Q39175318 | Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection |
| Q36275312 | Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo |
| Q28553478 | Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems |
| Q42680012 | Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. |
| Q33781930 | Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis? |
| Q52672813 | Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice. |
| Q52699502 | Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules. |
| Q99719959 | Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models |
| Q38495057 | Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives |
| Q24201000 | Drugs for treating Schistosoma mansoni infection |
| Q24194447 | Drugs for treating urinary schistosomiasis |
| Q36572029 | Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children |
| Q50781056 | Effect of Mirazid in Schistosoma japonicum-infected mice: parasitological and pathological assessment. |
| Q39338872 | Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection. |
| Q38974529 | Effect of gold nanoparticles on mice splenomegaly induced by schistosomiasis mansoni |
| Q47872179 | Effect of ozonide OZ418 against Schistosoma japonicum harbored in mice |
| Q33449456 | Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice |
| Q47998506 | Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits |
| Q51456665 | Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. |
| Q57116125 | Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro |
| Q92238880 | Effects of the Environment on Developmental Plasticity and Infection Success of Schistosoma Parasites - An Epigenetic Perspective |
| Q39439977 | Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis |
| Q47094509 | Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon |
| Q33800953 | Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial |
| Q28484235 | Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium |
| Q57805340 | Efficacy comparison between long-term high-dose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study |
| Q34081597 | Efficacy of Essential Oils of Thymus vulgaris and Origanum vulgare on Echinococcus granulosus |
| Q92892485 | Efficacy of Ozoroa pulcherrima Schweinf methanolic extract against Schistosoma mansoni-induced liver injury in mice |
| Q39576151 | Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum |
| Q42939143 | Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial |
| Q21198915 | Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis |
| Q38867800 | Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety |
| Q90504787 | Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST) |
| Q33528954 | Electroporation facilitates introduction of reporter transgenes and virions into schistosome eggs. |
| Q90179467 | Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment |
| Q24601973 | Epidemiology and control of human gastrointestinal parasites in children |
| Q34159188 | Epigenetic control of gene function in schistosomes: a source of therapeutic targets? |
| Q33891612 | Eukaryotic protein kinases (ePKs) of the helminth parasite Schistosoma mansoni |
| Q90700581 | Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni |
| Q38966422 | Evaluation of the in vitro activity of dermaseptin 01, a cationic antimicrobial peptide, against Schistosoma mansoni |
| Q27303844 | Evidence for Novel Pharmacological Sensitivities of Transient Receptor Potential (TRP) Channels in Schistosoma mansoni |
| Q39574584 | Exosome-like vesicles derived by Schistosoma japonicum adult worms mediates M1 type immune- activity of macrophage |
| Q89054345 | Experimental avian philophthalmosis: Evaluation of diagnosis and treatment of chickens infected with Philophthalmus gralli (Trematoda: Philophthalmidae) |
| Q37694858 | Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis |
| Q34281731 | Expression profile of the Schistosoma japonicum degradome reveals differential protease expression patterns and potential anti-schistosomal intervention targets |
| Q83131540 | FLOTAC: new multivalent techniques for qualitative and quantitative copromicroscopic diagnosis of parasites in animals and humans |
| Q28607183 | Fast evolutionary rates associated with functional loss in class I glucose transporters of Schistosoma mansoni |
| Q24650873 | Food-borne trematodiases |
| Q37787339 | From innovation to application: Social–ecological context, diagnostics, drugs and integrated control of schistosomiasis |
| Q47988412 | Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro |
| Q27680669 | Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites |
| Q28478288 | Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni |
| Q37282903 | Genomic linkage map of the human blood fluke Schistosoma mansoni |
| Q28481592 | Germline transgenesis and insertional mutagenesis in Schistosoma mansoni mediated by murine leukemia virus |
| Q33730904 | Gonad RNA-specific qRT-PCR analyses identify genes with potential functions in schistosome reproduction such as SmFz1 and SmFGFRs. |
| Q38205649 | HIV and schistosomiasis co-infection in African children |
| Q43857691 | Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice |
| Q33745207 | Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in Ghana |
| Q28551698 | High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni |
| Q46120029 | Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine |
| Q30245056 | History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination |
| Q34413522 | Human schistosomiasis |
| Q28476429 | IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni |
| Q33908196 | Identification of G protein-coupled receptors in Schistosoma haematobium and S. mansoni by comparative genomics |
| Q60932082 | Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production |
| Q37675128 | Imatinib activity on Schistosoma mansoni |
| Q28539623 | Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects |
| Q47349053 | Immune modulation of Th1, Th2, and T-reg transcriptional factors differing from cytokine levels in Schistosoma japonicum infection |
| Q34782228 | Immunology of human schistosomiasis |
| Q28551003 | Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal |
| Q26825064 | Impact of human schistosomiasis in sub-Saharan Africa |
| Q37292213 | In Vitro Schistosomicidal Activity of Phytol and Tegumental Alterations Induced in Juvenile and Adult Stages of Schistosoma haematobium |
| Q60924844 | In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets |
| Q28542999 | In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni |
| Q38648427 | In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium |
| Q27339703 | In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine |
| Q51301728 | In vitro evaluation of schistosomicidal potential of curcumin against Schistosoma japonicum. |
| Q99728045 | In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni |
| Q50893356 | In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors. |
| Q36660891 | In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates |
| Q36851347 | Inferences on the biochemical and environmental regulation of universal stress proteins from Schistosomiasis parasites |
| Q27304398 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel |
| Q40777879 | Inhibition of Tapeworm Thioredoxin and Glutathione Pathways by an Oxadiazole N-Oxide Leads to Reduced Mesocestoides vogae Infection Burden in Mice |
| Q28543846 | Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel |
| Q37840565 | Inhibitory activities of the marine streptomycete-derived compound SF2446A2 against Chlamydia trachomatis and Schistosoma mansoni. |
| Q64094995 | Insects in anthelminthics research: Lady beetle-derived harmonine affects survival, reproduction and stem cell proliferation of Schistosoma mansoni |
| Q40812997 | Interactions between mefloquine and the anti-fibrotic drug silymarin on Schistosoma mansoni infections in mice. |
| Q39126577 | Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro |
| Q36856181 | Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni |
| Q51741191 | Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome. |
| Q34782668 | Ion channels and drug transporters as targets for anthelmintics |
| Q51191319 | Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? |
| Q35105862 | Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays |
| Q40651231 | Large-Scale Overproduction and Purification of Recombinant Histone Deacetylase 8 (HDAC8) from the Human-Pathogenic Flatworm Schistosoma mansoni |
| Q46312164 | Lessons from a tarantula: new insights into myosin interacting-heads motif evolution and its implications on disease |
| Q30855808 | Lessons from implementing mass drug administration for soil transmitted helminths among pre-school aged children during school based deworming program at the Kenyan coast |
| Q37017439 | MCR synthesis of praziquantel derivatives |
| Q27663601 | Mapping the Catalytic Cycle of Schistosoma mansoni Thioredoxin Glutathione Reductase by X-ray Crystallography |
| Q93198814 | Medical Devices for Low- and Middle-Income Countries: A Review and Directions for Development |
| Q34366867 | Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies |
| Q28474353 | Mefloquine--an aminoalcohol with promising antischistosomal properties in mice |
| Q92919048 | Modifications of histones in parasites as drug targets |
| Q33552868 | Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel |
| Q51213476 | Molecular and structural characteristics of multidrug resistance-associated protein 7 in Chinese liver fluke Clonorchis sinensis. |
| Q46316485 | Molecular characterization of transport lectin vesicular integral membrane protein 36 kDa (VIP36) in the life cycle of Schistosoma mansoni |
| Q46760732 | Molecular characterization of voltage-gated calcium channel β-subunits of Clonorchis sinensis |
| Q36089897 | Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase |
| Q36834713 | Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel |
| Q39211542 | Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni |
| Q36656087 | Natural products as a source for treating neglected parasitic diseases |
| Q33745561 | Neuroschistosomiasis |
| Q53678341 | Neuroschistosomiasis |
| Q57482606 | Neuroschistosomiasis mimicking lower back pain: case report of a rare differential diagnosis in a pediatric patient |
| Q37177725 | New approaches for understanding mechanisms of drug resistance in schistosomes |
| Q35905176 | New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel |
| Q37943763 | New insight into praziquantel against various developmental stages of schistosomes |
| Q35813630 | New insights into the genetic diversity of Schistosoma mansoni and S. haematobiumin Yemen |
| Q38253124 | New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China. |
| Q27008897 | Novel therapeutic and prevention approaches for schistosomiasis: review |
| Q89169513 | Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development |
| Q38927082 | One hundred years of neglect in paediatric schistosomiasis |
| Q40223894 | Outbreak of Cleidodiscus in juvenile black crappies (Pomoxis nigromaculatus) and bath treatment with praziquantel. |
| Q39384158 | Ovicidal effect of Piperaceae species on Biomphalaria glabrata, Schistosoma mansoni host |
| Q40045772 | Paediatric and maternal schistosomiasis: shifting the paradigms. |
| Q34339707 | Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection |
| Q28484474 | Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children |
| Q64076106 | Performance of an Ultra-Sensitive Assay Targeting the Circulating Anodic Antigen (CAA) for Detection of Infection in a Low Endemic Area in Brazil |
| Q46921243 | Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni |
| Q49632990 | Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies |
| Q35159499 | Pharmacology and potential physiological significance of schistosome multidrug resistance transporters |
| Q39188232 | Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target |
| Q54646067 | Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? |
| Q36099895 | Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy. |
| Q64443565 | Population level changes in schistosome-specific antibody levels following chemotherapy |
| Q39160696 | Praziquantel derivatives with antischistosomal activity: aromatic ring modification |
| Q39164325 | Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. |
| Q28537753 | Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections |
| Q37192109 | Praziquantel treatment in trematode and cestode infections: an update |
| Q28540831 | Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial |
| Q37413446 | Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. |
| Q50590401 | Preliminary characterization and expression of Vasa-like gene in Schistosoma japonicum. |
| Q64989771 | Prevalence and risk factors of schistosomiasis and soil-transmitted helminthiases among preschool aged children (1-5 years) in rural KwaZulu-Natal, South Africa: a cross-sectional study. |
| Q36256196 | Prevalence of Schistosomes and Soil-Transmitted Helminths among Schoolchildren in Lake Victoria Basin, Tanzania |
| Q34510660 | Prevention and control of schistosomiasis: a current perspective |
| Q41722700 | Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study |
| Q27304864 | Protein kinase C and extracellular signal-regulated kinase regulate movement, attachment, pairing and egg release in Schistosoma mansoni |
| Q34173302 | Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis. |
| Q24203747 | Rapid screening and diagnostic tests for human schistosomiasis in endemic areas |
| Q33917776 | Receptor tyrosine kinases and schistosome reproduction: new targets for chemotherapy |
| Q34125799 | Research and development of antischistosomal drugs in the People's Republic of China a 60-year review |
| Q21144507 | Resolution of praziquantel |
| Q53696514 | Risk factors for hematemesis in Hoima and Buliisa Districts, Western Uganda, September-October 2015. |
| Q42176100 | Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice |
| Q84344062 | Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice |
| Q48670759 | Schistosoma mansoni Polo-like kinases and their function in control of mitosis and parasite reproduction |
| Q28533358 | Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets |
| Q33960332 | Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel |
| Q85346391 | Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis |
| Q39266759 | Schistosoma mansoni: In vitro schistosomicidal activity of piplartine |
| Q33531955 | Schistosoma mansoni: signal transduction processes during the development of the reproductive organs |
| Q34705514 | Schistosome ABC multidrug transporters: From pharmacology to physiology |
| Q91591248 | Schistosome TRP channels: An appraisal |
| Q64098812 | Schistosome infection and its effect on pulmonary circulation |
| Q38495049 | Schistosome sirtuins as drug targets |
| Q90859559 | Schistosomiasis |
| Q91816690 | Schistosomiasis |
| Q37133810 | Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study |
| Q39031600 | Schistosomiasis elimination: lessons from the past guide the future |
| Q42559175 | Schistosomiasis in Africa: an emerging tragedy in our new global health decade |
| Q37427116 | Schistosomiasis in African infants and preschool children: let them now be treated! |
| Q33825627 | Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. |
| Q33630932 | Schistosomiasis japonica control and research needs |
| Q83232661 | Schistosomicidal activity of the essential oil of Ageratum conyzoides L. (Asteraceae) against adult Schistosoma mansoni worms |
| Q35709480 | Schistosomicidal, hepatoprotective and antioxidant activities of the methanolic fraction from Clerodendrum umbellatum Poir leaves aqueous extract in Schistosoma mansoni infection in mice |
| Q61818153 | Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity |
| Q91899315 | Seldom Differential of Dysuria in Northern America |
| Q92657705 | Separation of praziquantel enantiomers using simulated moving bed chromatographic unit with performance designed for semipreparative applications |
| Q27331388 | Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement |
| Q34705820 | Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib |
| Q28547483 | Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial |
| Q36135568 | SjCa8, a calcium-binding protein from Schistosoma japonicum, inhibits cell migration and suppresses nitric oxide release of RAW264.7 macrophages |
| Q34328607 | SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis |
| Q36135715 | SmShb, the SH2-Containing Adaptor Protein B of Schistosoma mansoni Regulates Venus Kinase Receptor Signaling Pathways. |
| Q89272035 | Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice |
| Q44115782 | Stem cell therapy for the treatment of parasitic infections: is it far away? |
| Q27680126 | Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni |
| Q37409571 | Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis |
| Q28552326 | Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni |
| Q90191997 | Sulfonamide Inhibition Studies of an α-Carbonic Anhydrase from Schistosoma mansoni, a Platyhelminth Parasite Responsible for Schistosomiasis |
| Q38050973 | Susceptibility or resistance of praziquantel in human schistosomiasis: a review |
| Q28548401 | Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms |
| Q21560762 | Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis |
| Q90055083 | T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis |
| Q36692301 | THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL. |
| Q43924119 | The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on Schistosoma mansoni Infections: Its Implication on Undernutrition and Anaemia among Primary Schoolchildren in Two On-Shore Communities, Northwestern Tanzania |
| Q35754687 | The Epigenome of Schistosoma mansoni Provides Insight about How Cercariae Poise Transcription until Infection |
| Q46242772 | The RIO protein kinase-encoding gene Sj-riok-2 is involved in key reproductive processes in Schistosoma japonicum |
| Q28552173 | The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD) |
| Q39002257 | The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. |
| Q92912352 | The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni |
| Q34125793 | The drugs we have and the drugs we need against major helminth infections |
| Q35172249 | The effect of praziquantel and Carica papaya seeds on Hymenolepis nana infection in mice using scanning electron microscope |
| Q52325706 | The effects of subcurative praziquantel treatment on life-history traits and trade-offs in drug-resistant Schistosoma mansoni. |
| Q91898993 | The impact of cinnarizine and griseofulvin on juvenile and adult stages of Schistosoma mansoni |
| Q43256185 | The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum |
| Q60526096 | The inability of tapeworm Hymenolepis diminuta and fluke Dicrocoelium dendriticum to metabolize praziquantel |
| Q30502461 | The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy |
| Q26829701 | The redox biology of schistosome parasites and applications for drug development |
| Q37726847 | The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis |
| Q27694660 | The roles of water, sanitation and hygiene in reducing schistosomiasis: a review |
| Q30155988 | The β Subunit of Voltage-Gated Ca2+Channels |
| Q24201041 | Therapeutic and prophylactic drug interventions for Schistosomiasis japonicum |
| Q97517000 | Therapeutic efficacy of a newly synthesized benzimidazole compound BTP-OH against murine schistosomiasis mansoni |
| Q35535825 | Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases. |
| Q38495068 | Toward organometallic antischistosomal drug candidates |
| Q28472811 | Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes |
| Q28489110 | Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII |
| Q36125948 | Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole |
| Q37506661 | Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review |
| Q35228681 | Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child? |
| Q42672174 | Tyrosine kinase 4 is involved in the reproduction of the platyhelminth parasite Schistosoma japonicum |
| Q37705721 | Ultrastructural alterations in Schistosoma mansoni juvenile and adult male worms after in vitro incubation with primaquine. |
| Q47985342 | Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration |
| Q46497362 | Ultrastructural changes of adult Schistosoma mansoni worms recovered from C57BL/6 mice passively immunized with normal and vaccinated rabbit sera in vivo |
| Q28065987 | Universal Stress Proteins as New Targets for Environmental and Therapeutic Interventions of Schistosomiasis |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
| Q39569583 | Ureteric obstruction secondary to schistosomiasis 2 years after praziquantel therapy: a case report |
| Q33684408 | Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons |
| Q98188993 | Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy |
| Q86743127 | Vector-mediated microRNA-21 silencing ameliorates granulomatous liver fibrosis in Schistosoma japonicum infection |
| Q33686019 | Venus kinase receptors control reproduction in the platyhelminth parasite Schistosoma mansoni |
| Q64232154 | WIPO Re:Search-A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis |
| Q28254042 | WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships |
| Q30049251 | Water, Sanitation, and Hygiene (WASH): A Critical Component for Sustainable Soil-Transmitted Helminth and Schistosomiasis Control |
| Q21144493 | Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases |
| Q22122084 | Whole-genome sequence of Schistosoma haematobium |
| Q28534863 | Whole-organ isolation approach as a basis for tissue-specific analyses in Schistosoma mansoni |
| Q45340054 | [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity |
Search more.